Janssen Pharmaceuticals

E248879

Janssen Pharmaceuticals is a global pharmaceutical company, part of Johnson & Johnson, known for developing and marketing a wide range of prescription medicines across areas such as immunology, oncology, neuroscience, and cardiovascular disease.

All labels observed (8)

How this entity was disambiguated

Statements (48)

Predicate Object
instanceOf pharmaceutical company
subsidiary
brandOf Johnson & Johnson
country United States of America
surface form: United States
develops cancer therapies
cardiovascular and metabolic therapies
central nervous system therapies
infectious disease therapies
therapies for immune-mediated diseases
divisionOf Johnson & Johnson
surface form: Johnson & Johnson Innovative Medicine
engagesIn clinical trials
medical affairs
pharmaceutical marketing
regulatory affairs
field cardiovascular disease
gastroenterology
immunology
infectious diseases
metabolic disorders
neuroscience
oncology
psychiatry
pulmonary hypertension
focusesOn innovative medicines
unmet medical needs
foundedBy Paul Janssen
hasBusinessModel research-based pharmaceutical company
hasGlobalPresence true
hasPredecessor Janssen Pharmaceuticals self-linksurface differs
surface form: Janssen Pharmaceutica
headquartersLocation Beerse, Belgium
industry pharmaceutical industry
namedAfter Paul Janssen
operatesIn Africa
Asia
Europe
Latin America
Middle East
North America
parentOrganization Johnson & Johnson
partOf Johnson & Johnson
surface form: Johnson & Johnson pharmaceutical segment
productType biologic drugs
prescription medicines
small-molecule drugs
regulatoryFocus prescription-only medicines
researchArea clinical development
drug discovery
translational medicine
subsidiaryOf Johnson & Johnson

How these facts were elicited

Referenced by (18)

Full triples — surface form annotated when it differs from this entity's canonical label.

Xarelto isCoPromotedBy Janssen Pharmaceuticals
Darzalex marketedBy Janssen Pharmaceuticals
this entity surface form: Janssen-Cilag
Janssen COVID-19 Vaccine developer Janssen Pharmaceuticals
Janssen COVID-19 Vaccine manufacturer Janssen Pharmaceuticals
Janssen COVID-19 Vaccine trialSponsor Janssen Pharmaceuticals
Janssen COVID-19 Vaccine brandOwner Janssen Pharmaceuticals
Stelara isMarketedBy Janssen Pharmaceuticals
this entity surface form: Janssen
Janson isVariantSpellingOf Janssen Pharmaceuticals
this entity surface form: Janssen
Janssen Biotech parentOrganization Janssen Pharmaceuticals
Janssen Biotech partOf Janssen Pharmaceuticals
this entity surface form: Janssen Pharmaceutical Companies of Johnson & Johnson
Janssen Biotech brandFamily Janssen Pharmaceuticals
this entity surface form: Janssen
human adenovirus serotype 26 (Ad26) developerOfVectorPlatform Janssen Pharmaceuticals
subject surface form: human adenovirus serotype 26
this entity surface form: Janssen Vaccines
ENSEMBLE trial sponsor Janssen Pharmaceuticals
ENSEMBLE trial sponsor Janssen Pharmaceuticals
this entity surface form: Janssen Vaccines & Prevention B.V.
Ad26.COV2.S developer Janssen Pharmaceuticals
Ad26.COV2.S developer Janssen Pharmaceuticals
this entity surface form: Janssen Vaccines
Ad26.COV2.S manufacturer Janssen Pharmaceuticals
this entity surface form: Janssen Pharmaceuticals Companies of Johnson & Johnson
Janssen Pharmaceuticals hasPredecessor Janssen Pharmaceuticals self-linksurface differs
this entity surface form: Janssen Pharmaceutica